Pharmacoproteomics
Pharmacoproteomics is a rapidly emerging field in the pharmaceuticals industry which combines the use of large-scale proteomics technologies with bioinformatics to gain a better understanding of how proteins interact with drugs, leading to more effective drug designs and treatments. By identifying proteins that are involved in drug responses and understanding their structures, pharmacoproteomics enables scientists to develop more targeted drugs that are more specific to an individual’s needs, potentially reducing the risk of adverse side effects. It has the potential to revolutionize drug development and provide more personalized treatments that are tailored to individual patients.
← International Journal of Personalized MedicineRelated Articles
1 journal(s) foundInternational Journal of Personalized Medicine
ISSN: Coming Soon
Type: Open Access Journal
Editor-in-Chief: Tarek Magdy Mohamed, Northwestern University,
Department of Pharmacology and center of pharmacogenomics.
International Journal of Personalized Medicine aims to provide a personalized therapeutic strategy by considering factors influencing the response. These factors include patient related specific information. Applications and strategies need to be developed in order to improvise the existing treatment methods and put it into practical use. Personali